Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression.
A case of posterior reversible encephalopathy syndrome associated with gilenya(®) (fingolimod) treatment for multiple sclerosis.
A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field.
A silver lining of neuroinflammation: Beneficial effects on myelination.
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
CLIPPERS complicating multiple sclerosis causing concerns of CNS lymphoma.
Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study.
Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials.
Identification of naturally occurring Fatty acids of the myelin sheath that resolve neuroinflammation.
A study to evaluate the effect of ultrasound treatment on nodules in multiple sclerosis patients.
Magnetic resonance imaging outcomes from a phase III trial of teriflunomide.
Common and Rare Manifestations of Neuromyelitis Optica Spectrum Disorder.
Trimesta (Oral Estriol)
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity.
Zebrafish as a model to investigate CNS myelination.
Evaluation of quality of life and fatigue in radiologically isolated syndrome.
Myelin in cartilaginous fish.
Switch to natalizumab vs fingolimod in active relapsing-remitting multiple sclerosis.
Induction of a Unique Isoform of the NCOA7 Oxidation Resistance Gene by Interferon β-1b.
Multiple Sclerosis: Modulation of Toll-Like Receptor (TLR) Expression by Interferon-β Includes Upregulation of TLR7 in Plasmacytoid Dendritic Cells.
LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons.
Biogen Idec and Abbott Announce Enrollment of First Patient in Global Phase III Study of Daclizumab for Relapse Remitting Multiple Sclerosis
Dimethyl fumarate attenuates cerebral edema formation by protecting the blood-brain barrier integrity.
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain.
Teriflunomide in multiple sclerosis: Added benefit not proven
Pages
« first
‹ previous
…
78
79
80
81
82
83
84
85
86
…
next ›
last »